ELIGARD 7.5 MG POWDER FOR SOLUTION FOR INJECTION 7.5 mg Powder and solvent for solution for injection Vial
Product Overview
ELIGARD 7.5 mg Powder for Solution for Injection is a crucial prescription medication indicated for the palliative treatment of advanced prostate cancer.
It contains leuprolide acetate, a synthetic gonadotropin-releasing hormone (GnRH) analog, designed to continuously release the active ingredient over a one-month period.
This sustained-release formulation helps to achieve and maintain reduced serum testosterone levels, which is vital in managing hormone-sensitive prostate cancer.
Benefits of Use
ELIGARD 7.5 mg offers targeted hormonal therapy for advanced prostate cancer.
It helps in reducing the levels of testosterone, a hormone that fuels the growth of prostate cancer cells.
The extended-release formulation ensures consistent drug delivery, simplifying treatment regimens.
It aids in controlling disease progression and alleviating symptoms associated with advanced prostate cancer.
How to Use
ELIGARD 7.5 mg is administered as a subcutaneous injection, typically into the abdomen, upper thigh, or upper arm.
- This medication must be prepared and administered by a qualified healthcare professional.
- The powder is reconstituted with the provided solvent immediately prior to administration.
- Ensure the product reaches room temperature before mixing.
- Administer the entire dose subcutaneously, rotating injection sites as directed by your physician.
- Follow your doctor's instructions precisely regarding the dosing schedule, which is typically once a month.
Caution & Warnings
- ELIGARD can cause a temporary increase in testosterone levels during the first few weeks of treatment, potentially worsening symptoms.
- Patients may experience hot flashes, injection site reactions, fatigue, and pain in extremities.
- Monitor for potential cardiovascular events, diabetes, and neurological side effects.
- Not for use in women or pediatric patients.
- Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements.
- Do not administer intravenously.
- Regular monitoring of prostate-specific antigen (PSA) and testosterone levels is recommended.
Ingredients
Active Ingredient: Leuprolide Acetate 7.5 mg
Excipients: N-methyl-2-pyrrolidone, poly(DL-lactide-co-glycolide).
Product Details
Brand: Eligard
Manufacturer: Astellas Pharma
Dosage Form: Powder for Solution for Injection
Strength: 7.5 mg
Package Type: Vial and pre-filled syringe kit
Storage: Store at room temperature (20-25°C), excursions permitted to 15-30°C. Do not refrigerate.
| Gtin | 2504245205 |
|---|---|
| Recommended Sale Price | 313.9 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | LEUPRORELIN |
| SFDA Reg. No | 2504245205 |
| IBC | 2504245205 |
| Drug Type | Prescription |
| Scientific Name | Leuprolide acetate |
| Strength | 7.5 |
| Strength Unit | mg |
| Form | Powder and solvent for solution for injection |
| Admin Route | Subcutaneous injection |
| Size | 1 |
| Size Unit | kit |
| Package Types | Vial and pre-filled syringe kit |
| Package Size | 1 kit |
| shelfLife | 24 months |
| Storage conditions | Store at room temperature (20-25°C), excursions permitted to 15-30°C. |
| Refrigerator Storage | No |
